[Endocrinometabolic disorders in chronic obstructive pulmonary disease]
Irene Torres-Sánchez1, Marie Carmen Valenza, Fernando Carrasco
1Departamento de Fisioterapia, Facultad de Ciencias de la Salud, Universidad de Granada, Granada, España.
Nutricion Hospitalaria
|July 30, 2013
Summary
Endocrinometabolic disorders like diabetes and obesity are common in Chronic Obstructive Pulmonary Disease (COPD) patients, impacting their health. Recognizing these conditions is crucial for better COPD management and patient outcomes.
Area of Science:
- Pulmonary Medicine
- Endocrinology
- Metabolic Disorders
Context:
- Chronic Obstructive Pulmonary Disease (COPD) is frequently accompanied by endocrinometabolic disorders.
- These comorbidities significantly impact patient prognosis and clinical presentation.
- Understanding these associations is vital for developing effective preventive and diagnostic strategies.
Purpose:
- To determine the prevalence of endocrinometabolic diseases in individuals with COPD.
- To identify risk factors associated with these co-occurring conditions.
Summary:
- A systematic literature review identified a significant association between COPD and conditions including diabetes mellitus, metabolic syndrome, obesity, osteoporosis, and hypogonadism.
- These comorbidities are reported to be highly prevalent in COPD patients.
- Evidence suggests these conditions influence the development and progression of COPD.
Impact:
- Healthcare professionals managing COPD patients must consider these prevalent comorbidities.
- Improved understanding of COPD-related endocrinometabolic disorders can lead to enhanced treatment protocols and improved patient outcomes.
More Related Videos
Related Concept Videos
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...